CBFP
BMY icon

Cedar Brook Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Cedar Brook Financial Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,250
Closed -$610K – 60
2024
Q1 		$610K Buy
11,250
+333
+3% +$17K 0.12% 178
2023
Q4 		$548K Buy
10,917
+869
+9% +$45.6K 0.12% 182
2023
Q3 		$583K Sell
10,048
-253
-2% -$15.5K 0.15% 148
2023
Q2 		$659K Buy
10,301
+1,930
+23% +$129K 0.16% 146
2023
Q1 		$580K Buy
8,371
+1,451
+21% +$102K 0.15% 157
2022
Q4 		$498K Buy
6,920
+1,110
+19% +$83.7K 0.14% 172
2022
Q3 		$413K Buy
5,810
+2,306
+66% +$167K 0.13% 187
2022
Q2 		$270K Buy
3,504
+483
+16% +$36.8K 0.08% 261
2022
Q1 		$221K Buy
+3,021
New +$203K 0.06% 341
2021
Q3 		– Sell
-3,072
Closed -$205K – 353
2021
Q2 		$205K Sell
3,072
-126
-4% -$8.22K 0.06% 351
2021
Q1 		$202K Sell
3,198
-926
-22% -$57.6K 0.07% 304
2020
Q4 		$256K Sell
4,124
-929
-18% -$57.1K 0.09% 247
2020
Q3 		$305K Buy
5,053
+166
+3% +$9.99K 0.12% 198
2020
Q2 		$287K Buy
4,887
+799
+20% +$47.8K 0.13% 196
2020
Q1 		$228K Sell
4,088
-543
-12% -$33.2K 0.13% 205
2019
Q4 		$297K Buy
+4,631
New +$265K 0.13% 207

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cedar Brook Financial Partners's BMY Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 11,250 shares — an estimated $610K sold.

Cedar Brook Financial Partners first reported a position in BMY in Q4 2019 and held it in 16 quarters. The position peaked at $659K in Q2 2023. 2,154 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 11,250 Bristol-Myers Squibb shares in Q2 2024, an estimated $610K.
  • Cedar Brook Financial Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 16 quarters.
  • Cedar Brook Financial Partners's Bristol-Myers Squibb position peaked at $659K in Q2 2023.
  • 2,154 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.